N, M., L, T., J, M., M, T., A, J., & M, B. (2026). Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer. PloS one, 21(7), e0353941. https://doi.org/10.1371/journal.pone.0353941
Chicago Style (17th ed.) CitationN, Mäenpää, Tiainen L, Martikainen J, Tanner M, Jukkola A, and Bärlund M. "Real-world Implementation and Cost Impact Analysis of Oncotype DX Testing in Early-stage Breast Cancer." PloS One 21, no. 7 (2026): e0353941. https://doi.org/10.1371/journal.pone.0353941.
MLA (9th ed.) CitationN, Mäenpää, et al. "Real-world Implementation and Cost Impact Analysis of Oncotype DX Testing in Early-stage Breast Cancer." PloS One, vol. 21, no. 7, 2026, p. e0353941, https://doi.org/10.1371/journal.pone.0353941.